A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH)
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
A Study to Assess the Safety and Potential of Oral Insulin to Reduce Liver Fat Content in
Type 2 Diabetes Patients with Nonalcoholic Steatohepatitis (NASH)